Security Snapshot

RESMED INC - Ordinary Shares (RMD) Institutional Ownership

CUSIP: 761152107

13F Institutional Holders and Ownership History from Q1 2014 to Q2 2026

Latest Period

Q2 2026

Institutions Reporting

876

Shares (Excl. Options)

99,646,568

Price

$194.88

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.

Latest holder snapshot 5 signals
Portfolio coverage rank
0.01%
Share change
+2,437,045
Value change
+$456,155,829
Number of holders
876
Issuer context Names, identifiers, and filing context for this profile. 3 identity fields
Shares outstanding
145,199,667
SEC-reported price per share
$195.80
Insider filing price
$195.80
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors

Key facts

  • RMD - RESMED INC - Ordinary Shares is tracked under CUSIP 761152107.
  • 876 institutions reported positions in Q2 2026.
  • 3 significant owners is listed from Schedule 13D/13G reporting.

Change

  • Holder count moved from 936 to 876 between Q1 2026 and Q2 2026.
  • SEC-reported value moved from $21,806,284,842 to $19,442,918,633.

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Form 13F

Latest holder context comes from 876 institutions filings for Q2 2026.

Open SEC evidence

Security key

761152107

Latest holder period

Q2 2026

13F holders

876

13D/G owners

3

CIK / CUSIP context first

13D/G owners

Significant owners

Large-stake holder rows connected to Schedule 13D/G evidence.

Rows
3
Security
RMD
Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
VANGUARD CAPITAL MANAGEMENT LLC 8.2% $2,685,163,808 11,961,706 Vanguard Capital Management 31 Mar 2026
AustralianSuper Pty Ltd 5.7% $1,725,211,619 8,276,381 AustralianSuper Pty Ltd 30 Jun 2026
VANGUARD PORTFOLIO MANAGEMENT LLC 5.4% $1,770,359,051 7,886,489 Vanguard Portfolio Management 31 Mar 2026

As of 30 Jun 2026, 876 institutional investors reported holding 99,646,568 shares of RESMED INC - Ordinary Shares (RMD). This represents 69% of the company’s total 145,199,667 outstanding shares.

13F concentration

Top 25 institutional shareholders

Largest 13F positions for this security by reported shares and value.

Top holder share
47%
Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
BlackRock, Inc. 8.5% 12,317,194 +1.8% 0.04% $2,400,374,750
VANGUARD CAPITAL MANAGEMENT LLC 6.5% 9,474,129 +0.08% 0.04% $1,846,318,260
VANGUARD PORTFOLIO MANAGEMENT LLC 5.5% 7,913,661 +0.63% 0.07% $1,542,214,256
STATE STREET CORP 4.6% 6,680,735 +0.57% 0.04% $1,301,941,637
GEODE CAPITAL MANAGEMENT, LLC 3% 4,352,320 -0.01% 0.05% $845,164,181
Bank of New York Mellon Corp 2.9% 4,197,610 -15% 0.13% $818,030,203
FIRST TRUST ADVISORS LP 1.6% 2,278,696 +48% 0.26% $444,072,161
Invesco Ltd. 1.4% 2,063,578 +5.5% 0.03% $402,149,990
MORGAN STANLEY 1.3% 1,928,931 -28% 0.02% $375,910,899
NORTHERN TRUST CORP 1.2% 1,696,674 -1.7% 0.04% $330,647,829
NORDEA INVESTMENT MANAGEMENT AB 0.96% 1,388,008 +34% 0.22% $269,565,034
DEUTSCHE BANK AG\ 0.91% 1,322,313 -7.1% 0.07% $257,692,358
UBS Group AG 0.89% 1,289,300 +77% 0.04% $251,258,784
Swedbank AB 0.88% 1,274,897 -5.6% 0.21% $248,451,928
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 0.84% 1,222,473 +7.7% 0.03% $238,235,538
GOLDMAN SACHS GROUP INC 0.8% 1,160,426 +16% 0.02% $226,143,898
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP 0.78% 1,129,739 +151% 0.1% $220,163,536
DIMENSIONAL FUND ADVISORS LP 0.77% 1,123,577 +12% 0.04% $219,001,833
Legal & General Group Plc 0.65% 942,614 -4.8% 0.04% $183,696,617
AQR CAPITAL MANAGEMENT LLC 0.63% 910,623 +160% 0.06% $177,143,337
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC 0.59% 858,134 +1.1% 0.03% $167,233,153
JPMORGAN CHASE & CO 0.57% 833,536 +18% 0.01% $165,398,803
VANGUARD FIDUCIARY TRUST CO 0.56% 814,716 -1.3% 0.03% $158,771,854
BANK OF AMERICA CORP /DE/ 0.53% 775,424 -16% 0.01% $151,114,721
CITIGROUP INC 0.53% 774,425 +99% 0.07% $150,919,944

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
50
Latest
Q2 2026
Rows shown
1-25 of 50
Period 13F Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q2 99,646,568 $19,442,918,633 +$456,155,829 $194.88 876
2026 Q1 97,178,364 $21,806,284,842 -$15,586,389 $224.48 936
2025 Q4 96,983,178 $23,361,931,740 +$1,010,595,349 $240.87 941
2025 Q3 91,805,254 $25,120,556,319 -$164,908,411 $273.73 939
2025 Q2 92,309,428 $23,802,163,537 -$234,889,533 $258.00 911
2025 Q1 93,341,270 $20,873,665,746 +$659,205,153 $223.85 872
2024 Q4 90,103,150 $20,611,027,939 +$523,118,005 $228.69 863
2024 Q3 86,823,807 $21,178,183,309 +$357,448,956 $244.12 792
2024 Q2 85,413,001 $16,344,246,847 +$454,535,216 $191.42 768
2024 Q1 82,914,769 $16,411,147,126 +$513,359,778 $198.03 710
2023 Q4 80,394,822 $13,829,283,421 -$1,271,808,453 $172.02 680
2023 Q3 87,735,817 $12,964,369,891 -$1,617,256,395 $147.87 648
2023 Q2 95,075,328 $20,771,183,152 -$111,688,592 $218.50 724
2023 Q1 95,323,306 $20,870,559,574 +$76,827,102 $218.99 665
2022 Q4 95,570,997 $19,893,153,622 -$213,631,417 $208.13 717
2022 Q3 96,528,325 $21,085,043,390 -$40,809,623 $218.30 650
2022 Q2 96,423,808 $20,247,886,410 -$216,827,167 $209.63 661
2022 Q1 97,272,612 $23,607,128,509 +$638,048,061 $242.51 658
2021 Q4 94,533,097 $24,611,319,237 -$550,619,558 $260.48 703
2021 Q3 96,265,199 $25,370,506,829 -$115,406,017 $263.55 673
2021 Q2 96,700,199 $23,835,730,320 -$548,687,648 $246.52 650
2021 Q1 99,033,646 $19,213,495,080 -$384,053,397 $194.02 649
2020 Q4 101,297,957 $21,523,684,165 +$125,179,911 $212.56 652
2020 Q3 100,513,676 $17,230,325,953 -$286,391,481 $171.43 612
2020 Q2 102,006,987 $19,585,421,181 +$701,386,093 $192.00 567
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .